Kymera Therapeutics (KYMR) Cash from Operations (QoQ) (2020 - 2026)
Kymera Therapeutics (KYMR) Cash from Operations (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 69,146.49 Bn | 69,146.20 Bn | - |
| 2 | Nanobiotix | 1,942.19 Bn | 1,942.13 Bn | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - |
| 4 | BeOne Medicines | 475.42 Bn | 470.63 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 123.32 Bn | 116.08 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.80 Bn | 61.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 63.28 Bn | 63.28 Bn | - |
| 8 | Argenx Se | 56.67 Bn | 51.48 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 38.15 Bn | 38.15 Bn | - |
| 10 | Kymera Therapeutics | 10.92 Bn | 10.26 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -33.10% |
| Dec 31, 2025 | -146.21% |
| Sep 30, 2025 | 54.73% |
| Jun 30, 2025 | 24.34% |
| Mar 31, 2025 | -28.11% |
| Dec 31, 2024 | -23.10% |
| Sep 30, 2024 | -16.89% |
| Jun 30, 2024 | -8.45% |
| Mar 31, 2024 | -592.12% |
| Dec 31, 2023 | 125.42% |
| Sep 30, 2023 | 10.24% |
| Jun 30, 2023 | 19.81% |
| Mar 31, 2023 | -11.21% |
| Dec 31, 2022 | -15.37% |
| Sep 30, 2022 | 12.10% |
| Jun 30, 2022 | 3.25% |
| Mar 31, 2022 | -5.07% |
| Dec 31, 2021 | -2.93% |
| Sep 30, 2021 | -22.12% |
| Jun 30, 2021 | -33.69% |